FULVICIN-U/F Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fulvicin-u/f, and when can generic versions of Fulvicin-u/f launch?
Fulvicin-u/f is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in FULVICIN-U/F is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FULVICIN-U/F?
- What are the global sales for FULVICIN-U/F?
- What is Average Wholesale Price for FULVICIN-U/F?
Summary for FULVICIN-U/F
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| DailyMed Link: | FULVICIN-U/F at DailyMed |
Pharmacology for FULVICIN-U/F
| Drug Class | Tubulin Inhibiting Agent |
| Physiological Effect | Decreased Mitosis Microtubule Inhibition |
US Patents and Regulatory Information for FULVICIN-U/F
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | FULVICIN-U/F | griseofulvin, microsize | TABLET;ORAL | 060569-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | FULVICIN-U/F | griseofulvin, microsize | TABLET;ORAL | 060569-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
